HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

DSpace Repository

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Author: Nelde, Annika; Kowalewski, Daniel J.; Backert, Linus; Schuster, Heiko; Werner, Jan-Ole; Klein, Reinhild; Kohlbacher, Oliver; Kanz, Lothar; Salih, Helmut R.; Rammensee, Hans-Georg; Stevanovic, Stefan; Walz, Juliane S.
Tübinger Autor(en):
Nelde, Annika
Backert, Linus
Schuster, Heiko
Werner, Jan-Ole
Klein, Reinhild
Kohlbacher, Oliver
Kanz, Lothar
Rammensee, Hans-Georg
Stevanović, Stefan
Kowalewski, Daniel Johannes
Salih, Helmut Rainer
Walz, Juliane Sarah
Published in: Oncoimmunology (2018), Bd. 7, Article e1316438
Verlagsangabe: Taylor & Francis Inc
Language: English
Full text: http://dx.doi.org/10.1080/2162402X.2017.1316438
ISSN: 2162-402X
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)